Nasdaq Stocks

But the drug distributor also warns about the impact of elective medical procedures being postponed.

In trading on Monday, the SPDR— S&P— Biotech ETF is outperforming other ETFs, up about 2.6% on the day. Components of that ETF showing particular strength include shares of Cytokinetics, up about 23.8% and shares of Allakos, up about 14.6% on the day.

In trading on Monday, shipping shares were relative laggards, down on the day by about 5.6%. Helping drag down the group were shares of Scorpio Bulkers, down about 16.2% and shares of Genco Shipping & Trading Limited off about 9.1% on the day.

In trading on Monday, drugs shares were relative leaders, up on the day by about 2.5%. Leading the group were shares of Myokardia, up about 66.4% and shares of Oncolytics Biotech up about 26% on the day.

Investors focused on the Medical space have likely heard of Aerpio Pharmaceuticals (ARPO), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of ARPO and the res

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Aytu Bioscience (AYTU) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the se

Investors focused on the Basic Materials space have likely heard of DRDGOLD (DRD), but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector sho

Danaos Corporation DAC is scheduled to release first-quarter 2020 results on May 18, after market close.

Cohen & Steers CNS reported preliminary assets under management (AUM) of $62.1 billion as of Apr 30, 2020, which increased 8.3% from the prior-month level. Market appreciation of $4.2 billion and net inflows of $744 million were partially offset by distributions of $198 mill

Flowers Foods, Inc. FLO is scheduled to release first-quarter 2020 results on May 13. We note that this packaged bakery food company’s has a trailing four-quarter positive earnings surprise of 2.2%, on average.The Zacks Consensus Estimate for first-quarter 2020 earnings has be

As of late, it has definitely been a great time to be an investor Atara Biotherapeutics, Inc. ATRA.The stock has moved higher by 0.2% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest

Outsourcing is the practice of transferring control of certain operations, services or processes, previously done by a company’s internal staff or resources, to a third party.

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 11th:

Infinity Pharmaceuticals (INFI) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.

Service Properties (SVC) came out with quarterly funds from operations (FFO) of $0.75 per share, missing the Zacks Consensus Estimate of $0.89 per share. This compares to FFO of $0.88 per share a year ago. These figures are adjusted for non-recurring items.

GNC (GNC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of $0.06. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for non-recurring items.

Investors are always looking for stocks that are poised to beat at earnings season and Dynatrace, Inc. DT may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Dynatrace is seeing favorable e

U.S. stocks ended mixed as investors weighed optimism for a quick rebound in economic activity and the risk that reopening would lead to an uptick in coronavirus cases.

CEO Judy Marks says the newly independent elevator company will seek to expand its lucrative services business.

Canadian cannabis company Tilray (TLRY) is set to report first quarter fiscal 2020 earnings results after the closing bell Monday.